Intel Just 52-Week High: Buy, Hold or Sell at $140
Intel reached a fresh 52-week high as its foundry strategy gains traction and data-center demand strengthens. The sto...
Ways To Leverage Spending Analysis For Budgeting
Learn practical methods to use spending analysis for sharper budgeting. This guide shows how to turn data into smarter spending decisions.
19,062 articlesLip-Bu Tan’s Magic Worn? Intel’s Gains Slip Back Sharply
Intel shares retreat after a rally fueled by Lip-Bu Tan’s turnaround plan, as investors await Q2 results and the AI d...
First Major Enforcement Group Backs Clarity Act Now
NOBLE, the National Organization of Black Law Enforcement Executives, has endorsed the Clarity Act, becoming the firs...
Berkshire Hathaway Sitting Record Cash: Abel Era Buy?
Greg Abel leads Berkshire Hathaway as the company holds a record cash pile. This in-depth guide explains what that me...
Comcast Buys British Broadcaster a Week After Spin-Off
Comcast announced a UK broadcaster acquisition just days after revealing NBCUniversal’s spin-off plan, signaling a bo...
Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Astera Labs Chairman Manuel: Should You Sell ALAB?
A high-profile insider move has many ALAB investors wondering what comes next. This article breaks down the $60.5 mil...
BNB Chain Builds Layer Agentic L1 for 2027 Mainnet
BNB Chain announced a new Layer 1 focused on agentic trading, aiming for sub-50ms preconfirmation and no public mempo...
Some Area Homes Selling $1M Above Ask as AI Boom Surges
June data show a surge in premium closings as AI-fueled demand squeezes supply in the Bay Area luxury market. Some ar...
Credit Score Milestones What They Mean for Investors
As markets swing in 2026, credit score milestones continue to shape loan terms and funding access. This report explai...
When UWM Walked Away From Harbors: A Shareholder Win
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status